Prostate Cancer Archives - Page 199 of 207 - Renal and Urology News

Prostate Cancer

Medication Lowers Risk of First SRE

PARIS—Zoledronic acid reduces the risk of a first skeletal-related event (SREs) in patients with early malignant bone disease associated with hormone-refractory prostate cancer (HRPC).

HGPIN Is A Bad Sign

High-grade prostatic intraepithelial neoplasia (HGPIN) in retropubic radical prostatectomy specimens predicts a significantly higher risk of biochemical recurrence of prostate cancer.

CRP Predicts Prostate Cancer Survival

CHICAGO—Elevated plasma levels of C-reactive protein (CRP) predict worse survival in patients with androgen-independent prostate cancer (AIPC) receiving docetaxel-based therapy, a study found.

Tumor Cells in Blood Predict Outcome.

CHICAGO—Circulating tumor cells (CTCs) in patients with castration-refractory prostate cancer (CRPC) may help predict how they will respond to chemotherapy, according to findings presented here at the American Society of Clinical Oncology annual meeting.

Next post in News